USPTO 2015–2025 USPTO PatentsView US Corporation

Mylan Inc.

USPTO PatentsView assignee record - 41 granted patents across 36 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

20.1

Avg claims per patent

-72%

5-year filing velocity

The verdict

Mylan holds 41 US patents across 36 technology areas, rank #7,891 of 50,000 tracked assignees.

#7,891
of 50,000 US assignees by volume: Top 19%
by Innovation Score (47.2/100): 20.1
avg claims per patent: -72%
filing velocity, last 5 yrs

Portfolio overview

Mylan Inc. has been granted 41 US utility patents between 2015 and 2024, placing Mylan Inc. at rank #7,891 across all assignees tracked by PlainPatent. This portfolio spans 36 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.1 claims per patent with primary concentration in A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ). As a US Corporation, Mylan Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Mylan sits between Medtronic CV Luxembourg S.a.r.l. (41 patents, rank #7,887) and National University Corporation Ehime University (41 patents, rank #7,895) - the closest US assignees by grant volume. The composite Innovation Score of 47.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 9 grants, compared with 32 in the 2015–2019 window, a -72% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Mylan Inc.'s 20.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 36 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Mylan Inc. against peers pursuing similar technology classes.

Medtronic CV Luxe…

41
Miba Gleitlager A…

41
Midtronics

41
Mobilitie

41
Noble House HOME…

41
Nuvotronics

41
Nasuni

41
National Universi…

41
Mylan ◀

41

What this shows Mylan holds 41 patents at rank #7,891, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mylan

By rank, the assignees closest to #7,891 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Mylan's primary technology class.

Mylan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Mylan Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	12.2%
2016	6	14.6%
2017	12	29.3%
2018	3	7.3%
2019	6	14.6%
2020	5	12.2%
2021	2	4.9%
2022	1	2.4%
2024	1	2.4%

Which technologies does Mylan Inc. patent most?

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 14

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 13

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 12

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 12

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 11

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 9

C09J - ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES 6

H04M - TELEPHONIC COMMUNICATION 6

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 6

G08B - SIGNALLING OR CALLING SYSTEMS; ORDER TELEGRAPHS; ALARM SYSTEMS 5

B32B - LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM 4

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 4

H04W - WIRELESS COMMUNICATION NETWORKS 4

B41C - PROCESSES FOR THE MANUFACTURE OR REPRODUCTION OF PRINTING SURFACES 4

G06Q - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR 3

Top 15 of 36 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Complex

Velocity Declining

Where it ranks

Overall rank by patents

#7,891

Across all tracked assignees

Innovation Score

47.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Mylan Inc. hold?

Mylan Inc. holds 41 US granted patents filed between 2015 and 2024, spanning 36 technology areas.

What is Mylan Inc.'s Innovation Score?

Mylan Inc. has an Innovation Score of 47.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Mylan Inc. focus on?

Mylan Inc.'s top technology area is A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE) with 14 patents. The company has filed patents in 36 CPC subclasses total.

Is Mylan Inc.'s patent filing rate increasing or decreasing?

Mylan Inc.'s recent filing velocity is -72% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Mylan Inc.'s patents?

Mylan Inc.'s patents average 20.1 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Mylan Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Mylan's 41 grants land it in the top 19% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Mylan ranks #7,891 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61J - see who else leads that technology area. A61J leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.